Platinum – Name Badge
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost saving generic pharmaceuticals. We have more than 60 years’ history in Australia and employ around 800 associates across our three divisions. We believe continued R&D is essential to innovation and in Australia we invest around 20M annually in local clinical trials. Our mission is to discover new ways to improve and extend people’s lives.
To find out more about Novartis in Australia visit www.novartis.com.au
Platinum – Keynote Speaker
The Victorian Government has a proud history of supporting and enhancing cancer research in Victoria. Since 2006 the Victorian Government, through the Victorian Cancer Agency, has invested over $225 million to support translational research infrastructure, workforce initiatives and collaborative projects. High-quality cancer research drives clinical practice improvements and underpins our efforts in prevention, early detection, treatment, wellbeing and support. The Victorian cancer plan outlines the government’s long-term vision to improve cancer outcomes for all Victorians.
Gold – Dinner Sponsor
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. As an independent company, we plan in generations and focus on long-term success. Our goal is to improve the health and quality of life of patients and our focus is on diseases for which no satisfactory treatment option exists.
As a research-driven company, we actively collaborate with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.
Silver – Program & Handbook Sponsor
Gilead’s mission is to advance patient care by developing therapeutics to treat life threatening diseases. We apply biopharmaceutical science to create medicines to treat conditions in the areas of Haematology/Oncology (ZYDELIG® [idelalisib]), HIV, chronic hepatitis B, chronic hepatitis C and systemic fungal infections (AmBisome® [liposomal amphotericin B]).
Bronze – Breakfast Sponsor
The Victorian Comprehensive Cancer Centre is a powerful alliance of leading research, academic and clinical institutions working together to accelerate and amplify leading-edge cancer research, knowledge and expertise to benefit the Victorian community.
VCCC programs support and enable the alliance members to work strategically and collaboratively together, integrating cancer research, clinical trials and education, to enable and accelerate the translation of scientific evidence into patient and community benefit.
With the support of the Victorian Government, the VCCC seeks to reinforce Victoria’s position at the forefront of research-led, consumer-informed, cancer prevention, detection, treatment and patient care.
Exhibitor
eviQ is an Australian Government, free online resource of cancer treatment protocols developed by multidisciplinary teams of cancer specialists. eviQ provides evidence-based information to support health professionals in the delivery of cancer treatments at the point of care. Our goal to improve patient outcomes and reduce treatment variation. eviQ Education is the online learning arm of eviQ, and aims to standardise and promote evidence based practice through online learning resources.
Exhibitor
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalising healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
For further information visit www.siemens-healthineers.com/en-au/about
Exhibitor
The Victorian Government has a proud history of supporting and enhancing cancer research in Victoria. Since 2006 the Victorian Government, through the Victorian Cancer Agency, has invested over $225 million to support translational research infrastructure, workforce initiatives and collaborative projects. High-quality cancer research drives clinical practice improvements and underpins our efforts in prevention, early detection, treatment, wellbeing and support. The Victorian cancer plan outlines the government’s long-term vision to improve cancer outcomes for all Victorians.